Assignee
ONCOIMMUNE INC
US·9 granted patents·11 pending applications·17 citations·filing 2013–2021
Top patents by PatentIndex Score
20 records- 0195US10618960B2Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereofONCOIMMUNE INC·Filed 2016·Granted Apr 14, 2020·12 cites·14 claims
- 0282US10793617B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2018·Granted Oct 6, 2020·1 cites·14 claims
- 0382US9611309B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2014·Granted Apr 4, 2017·2 cites·17 claims
- 0481US8895022B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2013·Granted Nov 25, 2014·2 cites·9 claims
- 0572US2020399345A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 0671US2021161991A1Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 0769US2020147167A1Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 0865US2019255140A1Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2019·Application pending·0 cites
- 0963US9877998B2Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2017·Granted Jan 30, 2018·0 cites·6 claims
- 1062US2018177841A1Uses of hypoxia-inducible factor inhibitorsONCOIMMUNE INC·Filed 2017·Application pending·0 cites
- 1162US2017233453A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2017·Application pending·0 cites
- 1259US11571461B2Methods of use of soluble CD24 for treating lupus nephritisONCOIMMUNE INC·Filed 2018·Granted Feb 7, 2023·0 cites·11 claims
- 1358US2021162006A1Use of CD24 Proteins for Treating Leptin-Deficient ConditionsONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 1457US10799558B2Use of CD24 proteins for treating leptin-deficient conditionsONCOIMMUNE INC·Filed 2017·Granted Oct 13, 2020·0 cites·19 claims
- 1554US11911441B2Methods of use of CD24 for the prevention and treatment of leukemia relapseONCOIMMUNE INC·Filed 2019·Granted Feb 27, 2024·0 cites·16 claims
- 1652US2023108492A1Methods of use of soluble cd24 for treating viral pneumoniaONCOIMMUNE INC·Filed 2021·Application pending·0 cites
- 1750US2021046154A1Methods of use of soluble cd24 for treating acquired immune deficiency syndrome (hiv/aids)ONCOIMMUNE INC·Filed 2019·Application pending·0 cites
- 1850US2020181235A1Methods of use of soluble cd24 for neuroprotection and remyelinationONCOIMMUNE INC·Filed 2018·Application pending·0 cites
- 1948US2023103352A1Methods of use of soluble cd24 for treating sars-cov-2 infectionONCOIMMUNE INC·Filed 2021·Application pending·0 cites
- 2046US11547741B2Methods of use of soluble CD24 for treating immune related adverse events in cancer therapiesONCOIMMUNE INC·Filed 2018·Granted Jan 10, 2023·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →